Cargando…

Lovastatin Inhibits EMT and Metastasis of Triple-Negative Breast Cancer Stem Cells Through Dysregulation of Cytoskeleton-Associated Proteins

Triple-negative breast cancer (TNBC) is more aggressive and has poorer prognosis compared to other subtypes of breast cancer. Epithelial-to-mesenchymal transition (EMT) is a process in which epithelial cells transform into mesenchymal-like cells capable of migration, invasion, and metastasis. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Chanjuan, Yan, Shichao, Lu, Lu, Yao, Hui, He, Guangchun, Chen, Sisi, Li, Ying, Peng, Xiaojun, Cheng, Zhongyi, Wu, Mi, Zhang, Qiuting, Li, Guifei, Fu, Shujun, Deng, Xiyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212055/ https://www.ncbi.nlm.nih.gov/pubmed/34150623 http://dx.doi.org/10.3389/fonc.2021.656687

Ejemplares similares

Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells
por: Xue, Lian, et al.
Publicado: (2022)

Reversal of HER2 Negativity: An Unexpected Role for Lovastatin in Triple-Negative Breast Cancer Stem Cells
por: Yi, Huimei, et al.
Publicado: (2020)

Nucleolar and Coiled-Body Phosphoprotein 1 Is Associated With Stemness and Represents a Potential Therapeutic Target in Triple-Negative Breast Cancer
por: Chen, Sisi, et al.
Publicado: (2022)

Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis
por: Zhang, Qiuting, et al.
Publicado: (2021)

Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells
por: Wu, Di, et al.
Publicado: (2019)

Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma
por: Peng, Yikun, et al.
Publicado: (2017)

Nucleolar stress: is there a reverse version?
por: Lu, Lu, et al.
Publicado: (2018)

Effects of Lovastatin on MDA-MB-231 Breast Cancer Cells: An Antibody Microarray Analysis
por: Yang, Tao, et al.
Publicado: (2016)

Triple-negative breast cancer: is there a treatment on the horizon?
por: Yao, Hui, et al.
Publicado: (2016)

Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance
por: Zheng, Chanjuan, et al.
Publicado: (2023)

Structural basis for the biosynthesis of lovastatin
por: Wang, Jialiang, et al.
Publicado: (2021)

CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma
por: Huang, Deng, et al.
Publicado: (2017)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Microbial Production and Biomedical Applications of Lovastatin
por: Seenivasan, A., et al.
Publicado: (2008)

The role of lovastatin in the attenuation of COVID-19
por: Karampoor, Sajad, et al.
Publicado: (2021)

Effects of Lovastatin on Brain Cancer Cells
por: Amadasu, Efosa, et al.
Publicado: (2022)

EMT and tumor metastasis
por: Heerboth, Sarah, et al.
Publicado: (2015)

Differences Between Lovastatin and Simvastatin Hydrolysis in Healthy Male and Female Volunteers: Gut Hydrolysis of Lovastatin is Twice that of Simvastatin
por: Vree, Tom B., et al.
Publicado: (2003)

Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis
por: Zeng, Liang, et al.
Publicado: (2019)

Dysregulation of Cytoskeleton Remodeling Drives Invasive Leading Cells Detachment
por: Peng, Jei-Ming, et al.
Publicado: (2021)

PAI1: a novel PP1‐interacting protein that mediates human plasma's anti‐apoptotic effect in endothelial cells
por: Yao, Hui, et al.
Publicado: (2017)

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
por: Yi, Huimei, et al.
Publicado: (2021)

Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer
por: Kim, Min Soo, et al.
Publicado: (2016)

Lovastatin Protects against Experimental Plague in Mice
por: Ayyadurai, Saravanan, et al.
Publicado: (2010)

Improved bioavailability through floating microspheres of lovastatin
por: Kumar, S., et al.
Publicado: (2011)

Lovastatin‐Mediated Changes in Human Tendon Cells
por: Kuzma‐Kuzniarska, Maria, et al.
Publicado: (2015)

Optimization of lovastatin production from Aspergillus fumigatus
por: Mouafi, Foukia E., et al.
Publicado: (2016)

Nanoparticles of Lovastatin: Design, Optimization and in vivo Evaluation
por: Gaber, Dalia A
Publicado: (2020)

Influences of Lovastatin on membrane ion flow and intracellular signaling in breast cancer cells
por: Wei, Na, et al.
Publicado: (2006)

A bibliometric analysis of 16,826 triple-negative breast cancer publications using multiple machine learning algorithms: Progress in the past 17 years
por: Wang, Kangtao, et al.
Publicado: (2023)

Statistical parametrization of cell cytoskeleton reveals lung cancer cytoskeletal phenotype with partial EMT signature
por: Basu, Arkaprabha, et al.
Publicado: (2022)

Cortical inhibition in neurofibromatosis type 1 is modulated by lovastatin, as demonstrated by a randomized, triple-blind, placebo-controlled clinical trial
por: Bernardino, Inês, et al.
Publicado: (2022)

Isolation, Identification, and Characterization of an Unknown Impurity in Lovastatin EP
por: Belwal, Chandrakant, et al.
Publicado: (2014)

Lovastatin Production by Aspergillus sclerotiorum Using Agricultural Waste
por: Iewkittayakorn, Jutarut, et al.
Publicado: (2020)

Lovastatin as a supplement to mitigate rumen methanogenesis: an overview
por: Ábrego-Gacía, Amaury, et al.
Publicado: (2021)

Author Correction: Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer
por: Kim, Min Soo, et al.
Publicado: (2020)

Follistatin-Like 3 Enhances Invasion and Metastasis via β-Catenin-Mediated EMT and Aerobic Glycolysis in Colorectal Cancer
por: Li, Yuqiang, et al.
Publicado: (2021)

Role of EMT in Metastasis and Therapy Resistance
por: Smith, Bethany N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_re6l0kclt17vb9sbjv8f25s16g